The Hallmarks of COVID-19 Disease

Overview

Journal PLoS Pathog

Specialty Microbiology

Date 2020 May 23

PMID 32442210

Citations 236

Authors

Daolin Tang

Paul Comish

Rui Kang

Affiliations

Soon will be listed here.

Abstract

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a novel coronavirus that has caused a worldwide pandemic of the human respiratory illness COVID-19, resulting in a severe threat to public health and safety. Analysis of the genetic tree suggests that SARS-CoV-2 belongs to the same Betacoronavirus group as severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV). Although the route for viral transmission remains a mystery, SARS-CoV-2 may have originated in an animal reservoir, likely that of bat. The clinical features of COVID-19, such as fever, cough, shortness of breath, and fatigue, are similar to those of many acute respiratory infections. There is currently no specific treatment for COVID-19, but antiviral therapy combined with supportive care is the main strategy. Here, we summarize recent progress in understanding the epidemiological, virological, and clinical characteristics of COVID-19 and discuss potential targets with existing drugs for the treatment of this emerging zoonotic disease.

Citing Articles

Pharmacological mechanism of action of Lianhua Qingwen in the treatment of COVID-19 and facial neuritis.

Li G, Hao Z, Wang H, Wang C, Liu D, Chen L World J Otorhinolaryngol Head Neck Surg. 2025; 11(1):102-115.

PMID: 40070503 PMC: 11891286. DOI: 10.1002/wjo2.185.

Impact of the COVID-19 pandemic on the volume and diagnoses of patients admitted to the paediatric emergency department: a retrospective analysis from a third-level hospital in Northeastern Mexico.

Blanco-Murillo P, Estrada-Mendizabal R, Madrazo-Aguirre K, Ruelas-Martinez M, Escobedo-Berumen L, Pineda-Magana R BMJ Public Health. 2025; 3(1):e001101.

PMID: 40017971 PMC: 11816684. DOI: 10.1136/bmjph-2024-001101.

An explainable predictive machine learning model of gangrenous cholecystitis based on clinical data: a retrospective single center study.

Ma Y, Luo M, Guan G, Liu X, Cui X, Luo F World J Emerg Surg. 2025; 20(1):1.

PMID: 39757162 PMC: 11702024. DOI: 10.1186/s13017-024-00571-6.

Immune aging and infectious diseases.

Chen R, Zou J, Chen J, Wang L, Kang R, Tang D Chin Med J (Engl). 2024; 137(24):3010-3049.

PMID: 39679477 PMC: 11706578. DOI: 10.1097/CM9.0000000000003410.

Investigating DNA damage caused by COVID-19 and influenza in post COVID-19.

Abiri E, Mirzaii M, Moghbeli M, Atashi A, Harati A Mamm Genome. 2024; 36(1):200-212.

PMID: 39537997 DOI: 10.1007/s00335-024-10082-z.

References

Jiang S, Hillyer C, Du L . Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses. Trends Immunol. 2020; 41(5):355-359. PMC: 7129017. DOI: 10.1016/j.it.2020.03.007. View

Xie J, Li Y, Shen X, Goh G, Zhu Y, Cui J . Dampened STING-Dependent Interferon Activation in Bats. Cell Host Microbe. 2018; 23(3):297-301.e4. PMC: 7104992. DOI: 10.1016/j.chom.2018.01.006. View

Xie Y, Hou W, Song X, Yu Y, Huang J, Sun X . Ferroptosis: process and function. Cell Death Differ. 2016; 23(3):369-79. PMC: 5072448. DOI: 10.1038/cdd.2015.158. View

Lan J, Ge J, Yu J, Shan S, Zhou H, Fan S . Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature. 2020; 581(7807):215-220. DOI: 10.1038/s41586-020-2180-5. View

Heipertz E, Harper J, Walker W . STING and TRIF Contribute to Mouse Sepsis, Depending on Severity of the Disease Model. Shock. 2016; 47(5):621-631. DOI: 10.1097/SHK.0000000000000771. View

Chan J, Yuan S, Kok K, To K, Chu H, Yang J . A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020; 395(10223):514-523. PMC: 7159286. DOI: 10.1016/S0140-6736(20)30154-9. View

Zhou P, Yang X, Wang X, Hu B, Zhang L, Zhang W . A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 579(7798):270-273. PMC: 7095418. DOI: 10.1038/s41586-020-2012-7. View

Wrapp D, Wang N, Corbett K, Goldsmith J, Hsieh C, Abiona O . Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020; 367(6483):1260-1263. PMC: 7164637. DOI: 10.1126/science.abb2507. View

Al-Bari M . Chloroquine analogues in drug discovery: new directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases. J Antimicrob Chemother. 2015; 70(6):1608-21. PMC: 7537707. DOI: 10.1093/jac/dkv018. View

10.

Porcheddu R, Serra C, Kelvin D, Kelvin N, Rubino S . Similarity in Case Fatality Rates (CFR) of COVID-19/SARS-COV-2 in Italy and China. J Infect Dev Ctries. 2020; 14(2):125-128. DOI: 10.3855/jidc.12600. View

11.

Zhang T, Wu Q, Zhang Z . Probable Pangolin Origin of SARS-CoV-2 Associated with the COVID-19 Outbreak. Curr Biol. 2020; 30(8):1578. PMC: 7169893. DOI: 10.1016/j.cub.2020.03.063. View

12.

Lu R, Zhao X, Li J, Niu P, Yang B, Wu H . Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020; 395(10224):565-574. PMC: 7159086. DOI: 10.1016/S0140-6736(20)30251-8. View

13.

Savarino A, Gennero L, Sperber K, Boelaert J . The anti-HIV-1 activity of chloroquine. J Clin Virol. 2001; 20(3):131-5. DOI: 10.1016/s1386-6532(00)00139-6. View

14.

Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G . A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. N Engl J Med. 2020; 382(19):1787-1799. PMC: 7121492. DOI: 10.1056/NEJMoa2001282. View

15.

Elliott J, McMahon J, Chang C, Lee S, Hartogensis W, Bumpus N . Short-term administration of disulfiram for reversal of latent HIV infection: a phase 2 dose-escalation study. Lancet HIV. 2015; 2(12):e520-9. PMC: 5108570. DOI: 10.1016/S2352-3018(15)00226-X. View

16.

Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y . Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020; 382(13):1199-1207. PMC: 7121484. DOI: 10.1056/NEJMoa2001316. View

17.

Sze A, Belgnaoui S, Olagnier D, Lin R, Hiscott J, van Grevenynghe J . Host restriction factor SAMHD1 limits human T cell leukemia virus type 1 infection of monocytes via STING-mediated apoptosis. Cell Host Microbe. 2013; 14(4):422-34. DOI: 10.1016/j.chom.2013.09.009. View

18.

Remuzzi A, Remuzzi G . COVID-19 and Italy: what next?. Lancet. 2020; 395(10231):1225-1228. PMC: 7102589. DOI: 10.1016/S0140-6736(20)30627-9. View

19.

Wang C, Horby P, Hayden F, Gao G . A novel coronavirus outbreak of global health concern. Lancet. 2020; 395(10223):470-473. PMC: 7135038. DOI: 10.1016/S0140-6736(20)30185-9. View

20.

Channappanavar R, Fehr A, Vijay R, Mack M, Zhao J, Meyerholz D . Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice. Cell Host Microbe. 2016; 19(2):181-93. PMC: 4752723. DOI: 10.1016/j.chom.2016.01.007. View